Eva Domingo-Domenech

20PUBLICATIONS
103CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Personality and individual differencesMolecular targetsTumour immunologyInfectious diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 05, 2026
Sarcopenia in Patients With Cancer and Its Association With Chemotherapy-Induced Peripheral Neurotoxicity.

|Jan 28, 2026
Correction: Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up.

Eva Domingo-Domènech, Barbara Pro, Tim Illidge

|Dec 29, 2025
Brentuximab vedotin and nivolumab in combination with chemotherapy for nonbulky, early-stage classical Hodgkin lymphoma.

Jeremy S Abramson, David J Straus, Nancy L Bartlett

|Nov 26, 2025
Asparaginase Hypersensitivity Reactions in NK/T-Cell Lymphomas.

Javier Varela Gonzalez-Aller, Pablo Nadal, Salome Cañizares

|Aug 19, 2025
Association of PET4 response with outcomes of BV-CHP vs CHOP in the ECHELON-2 trial in CD30+ peripheral T-cell lymphoma.

Swaminathan Iyer, Neha Mehta-Shah, Ranjana Advani

|Aug 01, 2025
Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up.

Eva Domingo-Domènech, Barbara Pro, Tim Illidge

Pageof 4

Frequent Collaborators

6 joint publications

Pier Luigi Zinzani

3 joint publications

Kerry J Savage

3 joint publications

Marek Trneny

3 joint publications

Lorenz Trümper